BMA bemoans health service regulator re-think
November 2, 2007News that the health service is to get a new watchdog with increased powers has been criticised by the BMA, …
Marketing for maximum ROI impact
November 1, 2007Sales and Marketing marketing, strategy
From the amount of lip service the pharma industry pays to marketing effectiveness, you might be excused for thinking it …
Latest news from Datamonitor
October 29, 2007Sales and Marketing
Oxford BioMedica wins key ruling in patent disputeOxford BioMedica has received a favorable ruling in a US district court for …
NHS clinical effectiveness taskforce launched
October 25, 2007New measures to help the NHS use resources and technology more effectively have been unveiled by the government, spearheaded by …
Dwindling sales mean job cuts at GSK
October 25, 2007Sales and Marketing Avandia, diabetes
GlaxoSmithKline saw sales in its pharmaceutical division dip 2% in the third quarter, as falling demand for Avandia continued to …
AZ website supports mental health switching
October 25, 2007Medical Communications
AstraZeneca has launched a new website to support patients suffering from mental health conditions who want to change their drug …
Financial weak spots still plague NHS
October 25, 2007The health service is no longer running at a deficit, but new figures show that one third of PCTs and …
Biotech firms call for reform of European clinical trials
October 25, 2007Sales and Marketing
Biotech and specialist pharma companies have called for changes to European clinical trials regulations, which they say have imposed a …
Redefining pharmaceutical CRM
October 24, 2007Research and Development, Sales and Marketing CRM, customer relationship management, sales
Fierce generic competition, price containment regulations and poor pipeline productivity are challenges looming over many pharmaceutical companies today. In effect, …
Latest news from Datamonitor
October 24, 2007Research and Development
Abraxis gets FDA approval for chemotherapy drugAbraxis Pharmaceutical Products, the hospital-based business of Abraxis BioScience, has received FDA approval to …
Novartis changes pharma management after weak third quarter
October 19, 2007Sales and Marketing Novartis
Novartis has switched the heads of its consumer and pharmaceuticals divisions as part of a wider reorganisation of its pharma …
Genzyme expands UK presence
October 19, 2007Genzyme has opened its expanded UK headquarters in Oxford, underlining its rapid growth in the market.Andrew Smith, MP for Oxford …
New products behind Lilly growth
October 19, 2007Sales and Marketing lilly, zyprexa
Sales rose 19% for Lilly in the third quarter of the year, with depression treatment Cymbalta leading the growth in …
Pharma consultants on shortlist to help PCTs improve services
October 19, 2007Fourteen private companies have been awarded favoured supplier status to assist PCTs in their strategic planning and commissioning of services.The …
Pfizer abandons Exubera
October 19, 2007Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin
Once predicted to be a blockbuster, inhaled insulin product Exubera is to be abandoned by Pfizer because of poor sales.Exubera …
Underperforming NHS trusts threatened with takeover
October 18, 2007Health secretary Alan Johnson has warned the worst performing trusts in the NHS that they could face a takeover from …
Latest news from Datamonitor
October 18, 2007Research and Development
Advaxis cancer vaccine shows encouraging resultsBiotechnology company Advaxis has announced positive results from a Phase I/II first-in-man trial of a …
NHS spending growth slows
October 12, 2007The government will increase its health budget by £20 billion over the next three years, but the current record levels …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
